Back to Screener

HeartSciences Inc. Warrant (HSCSW)

Price$0.06

Favorite Metrics

Price vs S&P 500 (4W)-18.35%

All Metrics

Price vs S&P 500 (YTD)-13.84%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.01M
52-Week High$0.20
13-Week Price Return7.82%
3-Month Return Std Dev576.29%
Year-to-Date Return-7.69%
5-Day Price Return-8.22%
Month-to-Date Return-44.80%
Price vs S&P 500 (13W)4.96%
Beta7.97x
52-Week Low$0.03

Industry Peers — Orthopedic & Prosthetic Devices(26)

SymbolP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
HSCSWHeartSciences Inc. Warrant
$0.06
ISRGIntuitive Surgical Inc.
16.54x18.22%66.00%29.27%$465.60
EWEdwards Lifesciences Corp
7.77x6.70%78.01%18.41%$81.44
STESTERIS plc
3.81x12.49%44.11%17.03%$226.41
ZBHZimmer Biomet Holdings, Inc.
2.31x3.22%69.71%13.34%$95.48
ALGNAlign Technology Inc
3.41x10.30%68.27%13.53%$191.66
SNNSmith & Nephew plc
2.37x6.21%68.01%12.88%$34.21
MSAMine Safety Incorporated
3.60x6.82%46.46%19.83%$173.50
ESTAEstablishment Labs Holdings Inc.
9.30x20.04%69.32%-18.48%$66.93
ENOVEnovis Corporation
0.68x-6.05%58.16%-50.09%$26.27
CDRECadre Holdings, Inc.
2.19x8.57%42.54%11.04%$30.51

About

HeartSciences develops AI-powered ECG solutions for earlier detection of heart disease across clinical and point-of-care settings. The company offers two complementary products: MyoVista Insights, a cloud-based platform that integrates with existing ECG devices, and MyoVista wavECG Device, a standalone diagnostic tool. This dual approach enables broad adoption by healthcare providers seeking to improve cardiac screening capabilities.